Department of Psychiatry and Behavioral Neuroscience

·  If you have Bipolar I Disorder, you know that the mood-stabilizing drugs used to treat it can have different effects on each patient. You also know that finding the right medication(s) for you is mostly a process of trial and error, which can be hard on both patients and their families. This is why the University of Chicago is trying to identify genes that can help predict how a particular patient will respond to the mood-stabilizing drugs lithium and valproate. If you take lithium and it is working for you, or if you take another drug and it is not working for you, you may be eligible to participate in a bipolar treatment clinical study at the prestigious University of Chicago Medical Center. Study participants will receive the best care available, and compensation for research-related measurements.

Participants will be treated by a renowned psychiatrist, undergo a variety of clinical assessments and physiological tests, and complete self-report questionnaires and lab work. They will be prescribed a single bipolar medication, lithium or the alternative treatment, valproate; patients previously taking multiple drugs will benefit from reduced medication costs. Please consider taking part in this important study: you will not only receive the best available care and compensation, but will provide help for bipolar sufferers in general, by aiding us in our effort to improve the treatment of those afflicted with this devastating disease.

The University of Chicago Medical Center l  5841 S Maryland Ave, MC3077  l  Chicago IL 60637